Christine Lebrun Frenay is a professor of neurology who leads the Inflammatory Neurological Disorders Clinical Research Unit and MS Centre at the University of Nice Côte d'Azur, France. She has served as president of the French MS Society.
She was the first to describe a cohort with a subclinical form of MS in 2008. Subsequently, she co-founded the RIS Consortium with colleagues worldwide. Her research interests include therapeutic and MRI studies in MS. She is also the co-editor of MS-related recommendations for the French MS Society. In 2020, she received the Excellence Prize from Côte d'Azur University. Since 2023, she has been a member of the McDonald Committee.

Helmut Butzkueven is an academic neurologist specialising in Multiple Sclerosis research. He is the Van Cleef Roet Professor of Neuroscience at Monash University and the Director of Neurology at Alfred Health in Melbourne, Australia.
He is the Managing Director of the MS Base Foundation, a global MS registry established in 2004 that monitors outcomes of MS patients across 46 countries. He also co-leads international drug safety cohort studies in MSBase. His primary research focus includes the use of registry data, clinical and MRI data, cognitive testing, genomics, and patient selfmonitoring tools to optimise the benefits and safety of MS therapies and to identify strong predictors of disability progression.

Sandra Vukusic is a professor of neurology and head of the Multiple Sclerosis clinic at Lyon University Hospital, France. She serves as the scientific coordinator of the Observatoire Français de la Sclérose en Plaques (French MS registry). Her research mainly focuses on pregnancy in women with MS, contributing to a better understanding of the natural history (predicting post-partum relapses, the long-term impact of pregnancy on disability, subsequent pregnancies, and locoregional analgesia), and the use of DMTs in this context. She coordinated the 2022 French MS Society recommendations on pregnancy and MS. She led the development of French and ECTRIMS recommendations on immunisation in MS.

Jeannine Heckmann is a professor of neurology at the University of Cape Town (UCT), South Africa. She leads the neurology research group within the UCT Neurosciences Institute. Her research primarily focuses on neuromuscular diseases affecting Africans, particularly Myasthenia Gravis, MND/ALS, and inherited neuromuscular conditions. Her work explores various clinical and translational aspects of myasthenia. Her clinical and genomics research on MND and inherited neuromuscular diseases is ongoing, in collaboration with the UCT Clinical Omics & Informatics Unit, the International Centre for Genomic Medicine in Neuromuscular Diseases consortium, and the CReATe consortium led by the University of Miami. She established and led the ALS Africa network.

Umapathi N Thirugnanam is a Senior Neurologist at the National Neuroscience Institute, Singapore. His subspecialty interests include neuro muscular disorders, electrophysiology, neuroimmunology, the autonomic nervous system, and ocular movements. He has undertaken numerous teaching initiatives in Southeast Asian and African countries. He has received multiple teaching awards. He leads various health projects named Albatross, Woodpecker, Nightingale, and Crane, all aimed at providing access to neurology services in underresourced regions. He was awarded “Outstanding contribution to GBS100 book” in 2016. He received the “Honorary Membership” of the Association of Sri Lankan Neurologists in appreciation of the immense service he has provided towards the improvement of neurology care standards.

Stephen Reddel is a staff specialist neurologist at Concord Repatriation & General Hospital in Sydney and a consulting neurologist at the Brain & Mind Research Institute, University of Sydney. University of Sydney. He leads the neuroimmunology clinic at Concord Hospital, which specialises in the safe treatment of various neuroimmunological disorders of the CNS and PNS. His research interests include myasthenia gravis, focusing on the role of anti-MuSK antibodies and neuromuscular junction homeostasis; neuroimmunology, such as multiple sclerosis; and neurogenetics, including muscular dystrophies and inherited neuropathies. He is the chair of the National Blood Authority Neurology specialist working group and cochair of MGBase, a global myasthenia gravis registry.